Clinical trials have been conducted using drug compounds targeting one of the three causal genes, including ALDH2 (ranked as high confidence level in our findings), for alcohol dependency and parasite infection (two drugs, phase 4) [65]. This evidence concerns the gene ALDH2 and alcohol dependence.